Society guideline links: Management of mantle cell lymphoma

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●Society for Immunotherapy of Cancer (SITC): Clinical practice guideline on immunotherapy for the treatment of lymphoma (2020)

●International Lymphoma Radiation Oncology Group (ILROG): Guidelines on the optimal use of imaging in radiation therapy for lymphoma (2019)

●ILROG: Field and dose guidelines for modern radiation therapy for extranodal lymphomas (2015)

Canada

●Cancer Care Ontario (CCO): First-line therapy, autologous stem cell transplantation, and post-transplant maintenance in the management of patients newly diagnosed with mantle cell lymphoma (2020)

●Choosing Wisely Canada: Don't request a fine-needle aspirate (FNA) for the evaluation of suspected lymphoma (updated 2020)

●CCO: Safety considerations for the implementation of subcutaneous rituximab formulation (2018)

●CCO: Consensus pathology recommendations for complex malignant hematology (2016)

●CCO: PET imaging in lymphoma (2015)

●CCO: Rituximab in lymphoma and chronic lymphocytic leukemia – A clinical practice guideline (2015)

United States

●Choosing Wisely: Limit surveillance computed tomography (CT) scans in asymptomatic patients following curative-intent treatment for aggressive lymphoma (2013)

Europe

●European Society for Medical Oncology (ESMO): Consensus conference on malignant lymphoma – General perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma (2018)

●ESMO: Clinical practice guidelines for diagnosis, treatment and follow-up of newly diagnosed and relapsed mantle cell lymphoma (2017)

●ESMO: Consensus conferences – Guidelines on malignant lymphoma: Marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma (2013)

United Kingdom

●British Society for Haematology (BSH): Good practice paper on the diagnosis and investigation of patients with mantle cell lymphoma (2018)

●BSH: Guideline for the management of mantle cell lymphoma (2018)

Australia-New Zealand

●Choosing Wisely Australia: Limit surveillance computed tomography (CT) scans in asymptomatic patients with confirmed complete remission following curative intent treatment for aggressive lymphoma – except for patients on a clinical trial (reviewed 2015)

Japan

●Japanese Society of Hematology (JSH): Practical guidelines for hematological malignancies, 2018 – Lymphoma: Mantle cell lymphoma (MCL) (published 2019)